Accession Therapeutics’ ATTEST trial is a first-in-human Phase 1 trial in solid tumour patients, testing TROCEPT-01 (also known as ATTR-01). The trial is being delivered by Velindre University NHS Trust and Cardiff and Vale University Health Board.
Emma Williams, Senior Research Nurse Manager at the Velindre Cancer Service, has become the first nurse to be accepted onto the Cancer Research UK Women in Influence programme.
We issued a statement on 28 November regarding the departure of David Donegan from the organisation. The Trust has been clear that it will not comment on individual employment matters.
Llongyfarchiadau to Ashley, Carlie and Michele!
Velindre University NHS Trust is inviting artists from across Wales and beyond to attend an Artist Engagement Day.
At the 20th UKONS Conference in Birmingham, an inspiring awards ceremony highlighted outstanding contributions to cancer nursing across the UK. We are proud to announce that Val Harris, Immunotherapy Lead Nurse for the South East Wales Toxicity Service, was the recipient of the prestigious SACT Award and also earned a nomination in the Leadership category.